https://www.selleckchem.com/pr....oducts/filanesib.htm
There was no evidence of significant improvements in any efficacy outcomes when comparing ASMs with placebo or benzodiazepines. When compared with benzodiazepines, ASMs demonstrated significantly increased odds of requiring rescue medications (OR = 3.50, 95% CI = 1.32, 9.28; P=0.012). When comparing ASMs with placebo, there were significantly more dropouts because of adverse events (OR = 1.86, 95% CI = 1.05, 3.28; P=0.034). Most results were of very low quality with the majority of included studies conducted before 2000. This systemat
Like
Comment
Share
